Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.
Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...
Dupixent is a prescription injection that treats several conditions, including eczema, asthma, COPD, and rhinosinusitis. A copay card may assist you with Dupixent’s cost. Dupixent is a brand-name ...
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved ...
Aiming to offer an advantage over Dupixent (dupilumab, Regeneron Pharmaceuticals Inc.), dermatology-focused Galderma Holding SA won clearance from the U.S. FDA for Nemluvio (nemolizumab) as a ...
Most people with atopic dermatitis (a type of eczema) are able to control their symptoms by using topical treatments that are applied to the skin. But for some people with severe atopic dermatitis, ...
If you begin using Dupixent (dupilumab) and it works well for your condition, there’s no set time at which you would stop the medication. In most cases, you’ll stay on Dupixent long term, or as long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results